376 related articles for article (PubMed ID: 17562796)
1. 2-tert-butyl-8-quinolinamines exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization.
Huy NT; Mizunuma K; Kaur K; Nhien NT; Jain M; Uyen DT; Harada S; Jain R; Kamei K
Antimicrob Agents Chemother; 2007 Aug; 51(8):2842-7. PubMed ID: 17562796
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R
J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300
[TBL] [Abstract][Full Text] [Related]
3. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
[TBL] [Abstract][Full Text] [Related]
4. Quinoline drug-heme interactions and implications for antimalarial cytostatic versus cytocidal activities.
Gorka AP; de Dios A; Roepe PD
J Med Chem; 2013 Jul; 56(13):5231-46. PubMed ID: 23586757
[TBL] [Abstract][Full Text] [Related]
5. Mode of action of quinoline antimalarial drugs in red blood cells infected by
Kapishnikov S; Staalsø T; Yang Y; Lee J; Pérez-Berná AJ; Pereiro E; Yang Y; Werner S; Guttmann P; Leiserowitz L; Als-Nielsen J
Proc Natl Acad Sci U S A; 2019 Nov; 116(46):22946-22952. PubMed ID: 31659055
[TBL] [Abstract][Full Text] [Related]
6. Simple colorimetric inhibition assay of heme crystallization for high-throughput screening of antimalarial compounds.
Huy NT; Uyen DT; Maeda A; Trang DT; Oida T; Harada S; Kamei K
Antimicrob Agents Chemother; 2007 Jan; 51(1):350-3. PubMed ID: 17088494
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and blood-schizontocidal antimalarial activities of 2-substituted/2,5-disubstituted-8-quinolinamines and some of their amino acid conjugates.
Jain M; Vangapandu S; Sachdeva S; Jain R
Bioorg Med Chem; 2004 Mar; 12(5):1003-10. PubMed ID: 14980613
[TBL] [Abstract][Full Text] [Related]
8. Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors.
Hempelmann E
Parasitol Res; 2007 Mar; 100(4):671-6. PubMed ID: 17111179
[No Abstract] [Full Text] [Related]
9. Novel endoperoxide antimalarials: synthesis, heme binding, and antimalarial activity.
Taylor DK; Avery TD; Greatrex BW; Tiekink ER; Macreadie IG; Macreadie PI; Humphries AD; Kalkanidis M; Fox EN; Klonis N; Tilley L
J Med Chem; 2004 Mar; 47(7):1833-9. PubMed ID: 15027875
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives.
Solomon VR; Haq W; Srivastava K; Puri SK; Katti SB
J Med Chem; 2007 Jan; 50(2):394-8. PubMed ID: 17228883
[TBL] [Abstract][Full Text] [Related]
11. 5-Phenoxy Primaquine Analogs and the Tetraoxane Hybrid as Antimalarial Agents.
Jansongsaeng S; Srimongkolpithak N; Pengon J; Kamchonwongpaisan S; Khotavivattana T
Molecules; 2021 Jun; 26(13):. PubMed ID: 34208832
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR.
Skytte DM; Nielsen SF; Chen M; Zhai L; Olsen CE; Christensen SB
J Med Chem; 2006 Jan; 49(1):436-40. PubMed ID: 16392829
[TBL] [Abstract][Full Text] [Related]
13. A non-radiolabeled heme-GSH interaction test for the screening of antimalarial compounds.
Garavito G; Monje MC; Maurel S; Valentin A; Nepveu F; Deharo E
Exp Parasitol; 2007 Jul; 116(3):311-3. PubMed ID: 17336296
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and cellular localization of a fluorescent probe of the antimalarial 8-aminoquinoline primaquine.
McQueen A; Blake LD; Azhari A; Kemp MT; McGaha TW; Namelikonda N; Larsen RW; Manetsch R; Kyle DE
Bioorg Med Chem Lett; 2017 Oct; 27(20):4597-4600. PubMed ID: 28939120
[TBL] [Abstract][Full Text] [Related]
15. Heme polymerase activity and the stage specificity of antimalarial action of chloroquine.
Orjih AU
J Pharmacol Exp Ther; 1997 Jul; 282(1):108-12. PubMed ID: 9223546
[TBL] [Abstract][Full Text] [Related]
16. In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials.
Tripathi AK; Gupta A; Garg SK; Tekwani BL
Life Sci; 2001 Oct; 69(23):2725-33. PubMed ID: 11720077
[TBL] [Abstract][Full Text] [Related]
17. Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity.
Levatić J; Pavić K; Perković I; Uzelac L; Ester K; Kralj M; Kaiser M; Rottmann M; Supek F; Zorc B
Eur J Med Chem; 2018 Feb; 146():651-667. PubMed ID: 29407988
[TBL] [Abstract][Full Text] [Related]
18. Antiplasmodial activity of steroidal chalcones: evaluation of their effect on hemozoin synthesis and the new permeation pathway of Plasmodium falciparum-infected erythrocyte membrane.
Sisodia BS; Negi AS; Darokar MP; Dwivedi UN; Khanuja SP
Chem Biol Drug Des; 2012 Apr; 79(4):610-5. PubMed ID: 22248242
[TBL] [Abstract][Full Text] [Related]
19. Clotrimazole binds to heme and enhances heme-dependent hemolysis: proposed antimalarial mechanism of clotrimazole.
Huy NT; Kamei K; Yamamoto T; Kondo Y; Kanaori K; Takano R; Tajima K; Hara S
J Biol Chem; 2002 Feb; 277(6):4152-8. PubMed ID: 11707446
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait.
Martiney JA; Cerami A; Slater AF
Mol Med; 1996 Mar; 2(2):236-46. PubMed ID: 8726466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
